Atypical neuroleptics and selective attention in schizophrenia;Neuroleptiques atypiques et attention selective

Encephale

Volumn 25, Issue 3, 1999, Pages 260-264

  Stip, E ^a   Lussier, I ^b   Lalonde, P ^b   Luyet, A ^b   Fabian, J ^b  

^a CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

^b NONE

Author keywords

Attention; Clozapine; Cognition; Neuroleptic; Risperidone; Schizophrenia

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; RISPERIDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; NEGATIVE SYNDROME; SCHIZOPHRENIA; SELECTIVE ATTENTION; VISUAL STIMULATION; VOLUNTARY MOVEMENT; ATTENTION; CHRONIC DISEASE; DOSE RESPONSE; DRUG EFFECT; FEMALE; MALE; MIDDLE AGED; PHOTOSTIMULATION; TIME;

ADULT; ANTIPSYCHOTIC AGENTS; ATTENTION; CHRONIC DISEASE; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTIC STIMULATION; RISPERIDONE; SCHIZOPHRENIA; TIME FACTORS;

EID: 0032782573     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. ADDINGTON J, ADDINGTON D. Visual attention and symptoms of schizophrenia. Schizophr Res 1994 ; 11 : 155.
2. ANDREASEN N. The role of the thalamus in schizophrenia. Can J Psychiatry 1997 ; 42 : 27-43.
3. BERNARD D, LANÇON C, BOUGEROL T. Apport des modèles attentionnels à la compréhension des schizophrénies. Encephale 1997 ; 23 : 113-8.
4. CHOUINARD G, ROSS-CHOUINARD A, ANNABLE L et al. Extra-pyramidal symptom rating scale. Can J Neurol Sci 1980 ; 7 : 233.
5. GODBOUT R, BERGERON C, STIP E et al. A laboratory study of sleep and dreaming in a case of Asperger's Syndrome. Dreaming 1998 ; 8 (2) : 75-88.
6. GREEN M, MARSHALL BD, WIRSHING WC et al. Does risperidone improve verbal memory in treatment resistant schizophrenia ? Am J Psychiatry 1997 ; 54 : 799-804.
7. KAY SP FISZBEIN A, OPLER LA. The positive and negative syndrome scale. Schizophrenia Bull 1987 ; 13 : 261-76.
8. LUSSIER I, STIP E. Attention sélective et schizophrénie avant l'administration de neuroleptiques. Encephale 1998, in press.
9. LUSSIER I, STIP E. The effect of risperidone on cognitive and psychopathological manifestations of schizophrenia. CNS spectrum 1998, in press.
10. PICHOT P, OVERALL JE, SAMUEL-LAJEUNESSE B et al. Structure factorielle de l'échelle abrégée d'évaluation psychiatrique. Rev Psychol Appl 1969 ; 19 : 217-32.
11. STIP E. Memory impairment in schizophrenia : perspective from psychopathology and pharmacotherapy. Can J Psychiatry 1996 ; 41 (Suppl 2) : S27-34.
12. STIP E. From intrapsychic ataxia to cognitive dysmetria, From Stransky to Andreasen. Can J Psychiatry 1997 ; 41.
13. STIP E, GODBOUT R. Cortex préfrontal, monoamines et neuropsychologie de la schizophrénie. Med Sci 1995 ; 11 : 1531-9.
14. STIP E, LUSSIER I. Heterogeneity of the memory dysfunctioning in schizophrenia. Can J Psychiatry 1996 ; 41 (Suppl 1) : S14-20.
15. STIP E, LUSSIER I. The effect of risperidone on cognition in patients with schizophrenia. Can J Psychiatry 1996 ; 41 (Suppl 2) : S35-40.
16. STIP E, LUSSIER I, BABAI M et al. Seroquel and cognitive improvement in patient with schizophrenia. Biol Psychiatry 1996 ; 40 : 434-5.
17. STIP E, LUSSIER I, BABAI M et al. Atteintes cognitives précoces dans la démence précoce, résultats chez les jeunes schizophrènes non traités par les neuroleptiques. Med Sci 1995 ; 11 : 39.
18. TREISMAN A, SALO S. Conjunction search revisited. J Exp Psychol [Hum Percept] 1990 ; 16 : 25-42.